logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Sgx Pharmaceuticals, Inc.


USPTO Granted Patents = 17

% Expired Patents = 94.1


Forward Citations = 759

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Ruo W Steensma (14 out of 18 patents)

silverMedal Mark E Wilson (12 out of 26 patents)

bronzeMedal William D Arnold (12 out of 13 patents)

4.  Andreas Gosberg (12 out of 12 patents)

5.  Zhe Li (8 out of 56 patents)

6.  Ian A McDonald (8 out of 57 patents)

7.  Stephanie Hopkins (7 out of 9 patents)

8.  Stefan N Gradl (7 out of 7 patents)

9.  Chixu Chen (6 out of 14 patents)

10.  Pierre Bounaud (6 out of 6 patents)

11.  Pierre-Yves Bounaud (5 out of 6 patents)

12.  Brian Walter Eastman (4 out of 34 patents)

13.  Paul A Sprengeler (4 out of 4 patents)

14.  Christopher Ronald Smith (2 out of 29 patents)

15.  Elizabeth Anne Jefferson (2 out of 8 patents)


17 patents:

1. 8507489 - Bicyclic triazoles as protein kinase modulators (2013-08-13),
2. 8268994 - Fused ring heterocycle kinase modulators (2012-09-18),
3. 8242280 - Fused ring heterocycle kinase modulators (2012-08-14),
4. 8158647 - Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators (2012-04-17),
5. 8071581 - Triazolopyridazine protein kinase modulators (2011-12-06),
6. 7977481 - Pyrimidinyl-thiophene kinase modulators (2011-07-12),
7. 7906648 - Pyrrolo-pyridine kinase modulators (2011-03-15),
8. 7829558 - Fused ring heterocycle kinase modulators (2010-11-09),
9. 7803806 - Pyrimidinyl-thiophene kinase modulators (2010-09-28),
10. 7709645 - Pyrrolo-pyridine kinase modulators (2010-05-04),
11. 7626021 - Fused ring heterocycle kinase modulators (2009-12-01),
12. 7601839 - Pyrrolo-pyridine kinase modulators (2009-10-13),
13. 7582637 - Pyrrolo-pyridine kinase modulators (2009-09-01),
14. 7473783 - Bicyclic pyrazolo protein kinase modulators (2009-01-06),
15. 7452993 - Fused ring heterocycle kinase modulators (2008-11-18),
Company Overview
Sgx Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, focused on the development of innovative therapeutics for the treatment of cancer and other serious diseases. The company specializes in leveraging advanced drug discovery technologies and proprietary platforms to identify and optimize novel compounds. With a commitment to addressing unmet medical needs, Sgx Pharmaceuticals aims to bring transformative therapies to patients through rigorous research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

17 Patents

#339 in San Diego, CA

#4,509 in California

#18,881 in US

#35,887 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Sgx Pharmaceuticals, Inc.

Forward Citations = 759

26 inventors:

goldMedal Ruo W Steensma (14 out of 18 patents)

silverMedal Mark E Wilson (12 out of 26 patents)

bronzeMedal William D Arnold (12 out of 13 patents)

4.  Andreas Gosberg (12 out of 12 patents)

5.  Zhe Li (8 out of 56 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sgx Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/sgx-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…